Editorial
Published on 28 Mar 2023
Editorial: Advances in the understanding and treatment of cutaneous lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1190269
- 1,139 views
Type at least 3 characters
1,748 articles
Articles
Original Research
Published on 27 Mar 2023
Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1149298
- 2,907 views
- 6 citations
Case Report
Published on 27 Mar 2023
Interpreting flow cytometry with caution: A case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1170598
- 2,427 views
Review
Published on 24 Mar 2023
The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1148936
- 5,422 views
- 4 citations
Editorial
Published on 24 Mar 2023
Editorial: Inflammation and blood diseases, a dog chasing its tail
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1180559
- 882 views
Editorial
Published on 23 Mar 2023
Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1188375
- 772 views
Original Research
Published on 23 Mar 2023
Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1137175
- 3,309 views
- 4 citations
Review
Published on 23 Mar 2023
Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1130595
- 10,797 views
- 8 citations
Review
Published on 21 Mar 2023
Precision diagnostics in chronic lymphocytic leukemia: Past, present and future
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1146486
- 5,586 views
- 11 citations
Original Research
Published on 17 Mar 2023
CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1112879
- 3,581 views
- 4 citations
Review
Published on 17 Mar 2023
SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1116438
- 15,312 views
- 9 citations
Case Report
Published on 16 Mar 2023
Pathological fracture due to primary bone lymphoma in a patient with a history of prostate cancer: A case report and review of literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1100559
- 2,597 views
Original Research
Published on 16 Mar 2023
Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1138683
- 1,947 views
Review
Published on 15 Mar 2023
New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1143258
- 2,549 views
- 1 citation
Brief Research Report
Published on 15 Mar 2023
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1095870
- 2,875 views
- 10 citations
Case Report
Published on 15 Mar 2023
Case report: Invasive fungal infection in a patient with a rare CVID-causing gene (TNFRSF13B) mutation undergoing AML treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1017230
- 1,961 views